Taiwan FDA registration fbda0e53832bc5ec51b32189170963ca

"Meieliel" Precision Influenza A&B Virus Rapid Screening Test (Unsterilized)

TW: "美艾利爾" 精準流行性感冒A&B型病毒快速篩檢試驗 (未滅菌)

Taiwan·Risk Class 1·ALERE MEDICAL CO.,LTD CHIBA PLANT·Registered Oct 26, 2011 – Oct 26, 2021Cancelled

Registration details

Analysis ID: fbda0e53832bc5ec51b32189170963ca
Customs Code: DHA04401097807

Company information

Manufacturer: ALERE MEDICAL CO.,LTD CHIBA PLANT
Manufacturer Country: Japan
Authorized Representative: Abbott Rapid Diagnostics Health Corp.

Product details

Intended Use: Limited to the first level identification range of the Measures for the Administration of Medical Devices "Influenza Virus Serum Reagent (C.3330)".
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3330 流感病毒血清試劑
Import Information: import

Dates and status

Registration Date: Oct 26, 2011
Expiry Date: Oct 26, 2021
Cancellation Date: Oct 12, 2023

Cancellation information

Status: Logged out
Reason: 未展延而逾期者

About this record

Access comprehensive regulatory information for "Meieliel" Precision Influenza A&B Virus Rapid Screening Test (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number fbda0e53832bc5ec51b32189170963ca and manufactured by ALERE MEDICAL CO.,LTD CHIBA PLANT. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.